Page 6 - Analytical Testing News Today

Sumitomo Chemical provides high-quality oligonucleotides as drug substance for nucleic acid drugs to various customers. We offer an agile response to your nucleic acid drug discovery and development, based on the same trust and proven technology that we have cultivated in the manufacture of small-molecule API for more than 40 years.

The conference (with online and in-person content) is slated to gather professionals for deep conversations and lively collaboration on important topics.

Azzur opens new on-demand cleanroom facility in California The company’s Azzur Cleanrooms on Demand division has established another facility in Vista, a city in the San Diego Area, for life-sciences operations. Azzur Cleanrooms on Demand (a division of Azzur Group) has opened the doors on its latest facility in Vista, California. The facility is the second location, joining the first location that opened in 2018 in Waltham, Massachusetts. In addition to cleanroom ...

LANGLEY, BC / ACCESSWIRE / April 30, 2021 / Phyto Extractions Inc. (formerly Adastra Labs Holdings Ltd.

LANGLEY, BC / ACCESSWIRE / April 30, 2021 / Phyto Extractions Inc. (formerly Adastra Labs Holdings Ltd.) (CSE:XTRX) (FRA:D2EP) ("Phyto Extractions" or the "Company") announces that interim CEO J. Scott

Phyto Extractions Inc.: Phyto Extractions - Hydrocarbon Extraction Now Producing Shatter for Canadian Market LANGLEY, BC / ACCESSWIRE / April 21, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX) (Frankfurt:D2EP) ("Phyto Extractions" or the "Company) is pleased to announce that it is now producing cannabis shatter products for the Canadian market after wholly-owned subsidiary Adastra Labs Inc.s commissioning of new hydrocarbon extraction equipment ahead of schedule...

IQVIA completes acquisition of Q2 Diagnostics The clinical research tech specialists, which had held 60% of Q2 Diagnostics, will now wholly own the comprehensive clinical laboratory services company. IQVIA Holdings, which provides analytics, technology solutions and clinical research services to life-science clients, has acquired the remaining 40% of Q2 Solutions from diagnostic information services provider Quest Diagnostics. The companies report that $760m changed ...

A leader from Vocalis Health explains how health data can be culled from patient voice recordings to screen and monitor COVID-19 and other conditions. OSP: Could you please share the ‘elevator presentation’ description of Vocalis—who you are, what you do, and what sets you apart?​ SH: Vocalis Health is an AI health tech company pioneering the development of vocal biomarkers – where health-related information is derived from analysis of people’s voice reco...

The global medical device analytical testing outsourcing market size is expected to reach USD 9.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.6% from 2021 to 2028. Numerous medical device companies outsource analytical testing operations to minimize business risks, hasten product market entry, and reduce costs. These procedures lead to a significant rise in expenditure levels and, therefore, original equipment manufactur...

A peer-reviewed study indicates that the company’s antigen test could be more selective in detecting contagious COVID-19 patients than PCR testing.